Yang Jia Jin, Preston Gloria A, Alcorta David A, Waga Iwao, Munger William E, Hogan Susan L, Sekura Stephen B, Phillips Brian D, Thomas Robin P, Jennette J Charles, Falk Ronald J
Division of Nephrology, Department of Medicine, The University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Kidney Int. 2002 Nov;62(5):1638-49. doi: 10.1046/j.1523-1755.2002.00619.x.
Anti-neutrophil cytoplasmic autoantibodies (ANCA) induce neutrophil activation in vitro with release of injurious products that can mediate necrotizing vasculitis in vivo. The importance of ANCA IgG F(ab')2-antigen binding versus Fcgamma receptor engagement in this process is controversial. We propose that ANCA-antigen binding affects cell signaling pathways that can result in changes of gene expression.
Microarray GeneChip analysis and real-time, quantitative PCR (TaqMan(R)) was used to probe for transcripts in leukocytes from patients (in vivo gene expression study) and in leukocytes treated with ANCA IgG or ANCA-F(ab')2 (in vitro gene expression study).
Microarray gene chip analysis showed that ANCA IgG and ANCA-F(ab')2 stimulate transcription of a distinct subset of genes, some unique to whole IgG, some unique to F(ab')2 fragments, and some common to both. DIF-2, COX-2, and IL-8 were identified as genes responsive to ANCA signaling and were selected for in depth evaluation. In vitro DIF-2 and IL-8 were increased by both ANCA IgG and F(ab')2, but COX-2 only by MPO-ANCA F(ab')2. In vivo DIF-2 levels were increased in leukocytes of ANCA patients, which correlated strongly with disease activity and ANCA titer. DIF-2 was not increased in patients in remission or in disease control patients (systemic lupus erythematosus and IgA nephropathy). COX-2 gene expression was significantly increased in patients with active disease, while IL-8 was increased in remission.
The data indicate that leukocyte genes are activated in vitro by both ANCA Fc and ANCA F(ab')2 pathways and that in vitro activation mimics changes in circulating leukocytes of patients with ANCA disease. Increased levels of DIF-2 in patient leukocytes strongly correlate with severity of disease in kidney tissue. The observations indicate a previously unrecognized role for DIF-2 in ANCA-mediated inflammation, which raises the possibility that DIF-2 has an important role in other types of inflammation.
抗中性粒细胞胞浆自身抗体(ANCA)在体外可诱导中性粒细胞活化,释放出可在体内介导坏死性血管炎的有害产物。在此过程中,ANCA IgG F(ab')2与抗原的结合相对于Fcγ受体的参与的重要性存在争议。我们提出,ANCA与抗原的结合会影响细胞信号通路,进而导致基因表达的变化。
使用微阵列基因芯片分析和实时定量PCR(TaqMan®)来检测患者白细胞中的转录本(体内基因表达研究)以及用ANCA IgG或ANCA-F(ab')2处理的白细胞中的转录本(体外基因表达研究)。
微阵列基因芯片分析表明,ANCA IgG和ANCA-F(ab')2刺激了不同基因子集的转录,有些基因是全IgG特有的,有些是F(ab')2片段特有的,还有一些是两者共有的。DIF-2、COX-2和IL-8被确定为对ANCA信号有反应的基因,并被选作深入评估对象。在体外,DIF-2和IL-8均被ANCA IgG和F(ab')2升高,但COX-2仅被MPO-ANCA F(ab')2升高。在体内,ANCA患者白细胞中的DIF-2水平升高,这与疾病活动度和ANCA滴度密切相关。缓解期患者或疾病对照患者(系统性红斑狼疮和IgA肾病)的DIF-2未升高。活动性疾病患者的COX-2基因表达显著增加,而缓解期患者的IL-8增加。
数据表明,白细胞基因在体外被ANCA Fc和ANCA F(ab')2途径激活,且体外激活模拟了ANCA疾病患者循环白细胞中的变化。患者白细胞中DIF-2水平的升高与肾组织疾病严重程度密切相关。这些观察结果表明DIF-2在ANCA介导的炎症中具有先前未被认识到的作用,这增加了DIF-2在其他类型炎症中起重要作用的可能性。